Home > Insider Trading > Filing (0001209191-15-001080)

Filing Details

Accession Number:: 0001209191-15-001080
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-01-05 16:56:36
Reporting Period:: 2015-01-02

Filing Date:: 2015-01-05
Accepted Time:: 2015-01-05 16:56:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1218629	S Leonard Schleifer	777 Old Saw Mill River Rd Tarrytown NY 10591	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-01-02	1,500	$0.00	1,500	No	4	C	Indirect	by Trust for Son
Common Stock	Disposition	2015-01-02	397	$408.64	1,103	No	4	S	Indirect	by Trust for Son
Common Stock	Disposition	2015-01-02	300	$409.28	803	No	4	S	Indirect	by Trust for Son
Common Stock	Disposition	2015-01-02	403	$410.47	400	No	4	S	Indirect	by Trust for Son
Common Stock	Disposition	2015-01-02	200	$412.23	200	No	4	S	Indirect	by Trust for Son
Common Stock	Disposition	2015-01-02	100	$413.88	100	No	4	S	Indirect	by Trust for Son
Common Stock	Disposition	2015-01-02	100	$416.00	0	No	4	S	Indirect	by Trust for Son

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	by Trust for Son
No	4	S	Indirect	by Trust for Son
No	4	S	Indirect	by Trust for Son
No	4	S	Indirect	by Trust for Son
No	4	S	Indirect	by Trust for Son
No	4	S	Indirect	by Trust for Son
No	4	S	Indirect	by Trust for Son

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Class A Stock	Disposition	2015-01-02	1,500	$0.00	1,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,775			No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,650	Indirect	By 401(k) Plan
Common Stock	42,087	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Class A Stock	$0.00			1,710,790	1,710,790	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	1,710,790	1,710,790	Direct

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 397 shares of Company stock on January 2, 2015 at prices ranging from $408.33 to $408.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on January 2, 2015 at prices ranging from $409.13 to $409.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price.
Represents volume-weighted average price of sales of 403 shares of Company stock on January 2, 2015 at prices ranging from $410.07 to $410.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on January 2, 2015 at prices ranging from $412.13 to $412.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price.
Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
These shares of Class A Stock are presently convertible and such conversion feature does not expire.